. 2018 Nov 27;92(1094):20180584. doi: 10.1259/bjr.20180584

Table 1.

Indications for FDG PET-CT in paediatric malignancies as per current published guidelines

Malignancy	Disease	Published guidelines
Malignancy	Disease	EANM 2008¹	EANM 2009²	RCR 2014³	RCR 2016⁴
Haematological	Hodgkin's lymphoma	✓		✓	#
	Non-Hodgkin's lymphoma	✓		✓	#
	Extra medullary leukaemia			✓
	Langerhans cell histiocytosis			✓	✓
Nervous system	Neuroblastoma (MIBG negative)	✓		✓	✓
Nervous system	Selected brain tumours	✓	✓	✓	#
Sarcoma	Osteosarcoma	✓		✓	✓
	Ewing's sarcoma	✓		✓	✓
	Rhabdomyosarcoma	✓		✓	✓
	MPNST	✓		✓	✓
Solid organ	Germ cell tumour	✓		✓	#
	Hepatoblastoma	✓		✓	✓
	Wilms tumour	✓		✓	✓
Other	Malignancy of unknown origin	✓		✓	✓
	Biopsy target			✓	#
	Relapse	✓	✓	✓	#

EANM, European Association of Nuclear Medicine; FDG PET-CT, fluorodeoxyglucose positron emission tomography/CT; MIBG, metaiodobenzylguanidine; MPNST, malignant peripheral nerve sheath tumour; RCR, Royal College of Radiologists.

✓denotes paediatric-specific indication in guidance.

# denotes extrapolated indication from adult guidelines.